Skip to main content
. 2020 Sep 11;46:101682. doi: 10.1016/j.bpg.2020.101682

Table 1.

Outcomes after liver transplant from ELTR [4] of 106086 adults grafted between 1988 and 2015.

Indication 1 year 5 year 10 year 14 year 20 year
Acute liver failure 75% 65% 59% 55% 46%
Chronic liver disease 84% 72% 60% 51% 38%
Metabolic 87% 79% 71% 65% 57%
Malignant cancer 84% 63% 49% 40% 31%
Benign cancer 89% 84% 75% 66% 57%
Other 77% 68% 61% 56% 47%